AdaptHealth Corp. (AHCO) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$17.50M*; Operating income -$137.80M; Depreciation and amortization $120.30M*.
- 2026-03-31: Basis Reported; EBITDA $111.96M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $24.23M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $159.45M*; Operating income $61.73M; Depreciation and amortization $97.72M*.
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$17.50M* | -$137.80M | $120.30M* | $740.31M | -2.36%* | $166.24M* | $145.30M* | $636.10M | (m) | (m) | -$21.23M |
|---|
| 2026-03-31 | Reported | $111.96M | (m) | (m) | (m) | 13.66% | $121.21M | $93.72M | $708.30M | (m) | (m) | -$5.23M |
|---|
| 2025-12-31 | Reported | $24.23M | (m) | (m) | (m) | 2.86% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | $159.45M* | $61.73M | $97.72M* | $820.31M | 19.44%* | $94.24M* | $161.07M* | $658.37M | (m) | (m) | $10.60M |
|---|
| 2025-06-30 | Reported | $158.05M* | $65.69M | $92.36M* | $657.10M | 24.05%* | $88.67M* | $161.99M* | $521.31M | (m) | (m) | $32.78M |
|---|
| 2025-03-31 | Reported | $117.52M | (m) | (m) | (m) | 15.11% | $95.58M | $95.53M | $657.44M | (m) | (m) | $850.00K |
|---|
| 2024-12-31 | Reported | $188.2M | (m) | (m) | (m) | 21.97% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | $154.25M* | $63.49M | $90.76M* | $805.86M | 19.14%* | $59.56M* | $144.41M* | $643.79M | (m) | (m) | $8.07M |
|---|
| 2024-06-30 | Reported | $143.21M* | $52.05M | $91.16M* | $805.98M | 17.77%* | $81.27M* | $197.98M* | $636.62M | (m) | (m) | $7.25M |
|---|
| 2024-03-31 | Reported | $143.41M | (m) | (m) | (m) | 18.10% | $87.89M | $49.03M | $635.03M | (m) | (m) | $6.61M |
|---|
| 2023-12-31 | Reported | -$125.44M | (m) | (m) | (m) | -14.62% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$363.73M* | -$461.04M | $97.31M* | $804.03M | -45.24%* | $77.09M* | $98.83M* | $693.49M | (m) | (m) | -$34.58M |
|---|
| 2023-06-30 | Reported | $153.56M* | $54.26M | $99.30M* | $793.29M | 19.36%* | $82.61M* | $86.32M* | $673.40M | (m) | (m) | $5.40M |
|---|
| 2023-03-31 | Reported | $119.99M | (m) | (m) | (m) | 16.11% | $89.12M | $140.25M | $655.40M | (m) | (m) | -$1.71M |
|---|
| 2022-12-31 | Reported | $129.08M | (m) | (m) | (m) | 16.54% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | $145.28M* | $52.95M | $92.33M* | $756.50M | 19.20%* | $94.17M* | $107.02M* | $646.71M | (m) | (m) | $5.58M |
|---|
| 2022-06-30 | Reported | $138.65M* | $59.18M | $79.47M* | $727.61M | 19.06%* | $77.17M* | $103.47M* | $610.01M | (m) | (m) | $8.85M |
|---|
| 2022-03-31 | Reported | $128.58M | (m) | (m) | (m) | 18.21% | $77.17M | $66.45M | $597.12M | (m) | (m) | $5.60M |
|---|
| 2021-12-31 | Reported | $146.31M | (m) | (m) | (m) | 20.84% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | $145.54M* | $75.71M | $69.83M* | $653.29M | 22.28%* | $60.29M* | $27.13M* | $529.89M | (m) | (m) | $12.15M |
|---|
| 2021-06-30 | Reported | $129.20M* | $65.41M | $63.79M* | $617.02M | 20.94%* | $43.80M* | $129.24M* | $490.72M | (m) | (m) | $12.33M |
|---|
| 2021-03-31 | Reported | $62.62M | (m) | (m) | (m) | 12.99% | $35.60M | $18.38M | $396.70M | (m) | (m) | -$1.70M |
|---|
| 2020-09-30 | Reported | (m) | $13.26M | (m) | $284.40M | (m) | $11.92M* | $34.28M* | $240.72M | (m) | (m) | -$4.92M |
|---|
| 2020-06-30 | Reported | (m) | $15.57M | (m) | $232.12M | (m) | $3.38M* | $86.63M* | $198.42M | (m) | (m) | $1.83M |
|---|
| 2020-03-31 | Reported | (m) | $8.22M | (m) | $191.44M | (m) | $7.53M | $24.38M | $167.63M | (m) | (m) | -$1.64M |
|---|
| 2019-09-30 | Reported | (m) | $8.72M | (m) | $136.45M | (m) | $3.71M* | $17.14M* | $114.80M | (m) | (m) | $1.03M |
|---|
| 2019-06-30 | Reported | (m) | $14.91M | (m) | $124.15M | (m) | $5.44M* | $9.80M* | $102.15M | (m) | (m) | $2.00M |
|---|
| 2019-03-31 | Reported | (m) | $5.35M | (m) | $119.50M | (m) | $5.30M | $16.23M | $100.23M | (m) | (m) | $2.42M |
|---|
| 2018-09-30 | Reported | (m) | -$444.75K | (m) | (m) | (m) | (m) | -$356.44K* | (m) | (m) | (m) | $241.76K |
|---|
| 2018-06-30 | Reported | (m) | -$234.41K | (m) | (m) | (m) | (m) | -$533.28K* | (m) | (m) | (m) | $232.40K |
|---|
| 2018-03-31 | Reported | (m) | -$72.53K | (m) | (m) | (m) | (m) | -$380.19K | (m) | (m) | (m) | $72.05K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $472.8M | (m) | (m) | (m) | 14.57% | $382.39M | $601.77M | $2.64B | (m) | (m) | $50.88M |
|---|
| 2024-12-31 | Reported | $629.07M | (m) | (m) | (m) | 19.29% | $306.06M | $541.84M | $2.58B | (m) | (m) | $41.24M |
|---|
| 2023-12-31 | Reported | -$215.62M | (m) | (m) | (m) | -6.74% | $337.46M | $480.67M | $2.58B | (m) | (m) | -$49.00M |
|---|
| 2022-12-31 | Reported | $541.59M | (m) | (m) | (m) | 18.23% | $391.42M | $373.87M | $2.39B | (m) | (m) | $24.77M |
|---|
| 2021-12-31 | Reported | $483.66M | (m) | (m) | (m) | 19.70% | $203.31M | $275.68M | $2.01B | (m) | (m) | $32.81M |
|---|
| 2020-12-31 | Reported | $153.79M | (m) | (m) | (m) | 14.56% | $39.76M | $195.63M | $898.60M | (m) | (m) | -$11.96M |
|---|
| 2019-12-31 | Reported | $91.95M | (m) | (m) | (m) | 17.36% | $21.33M | $60.42M | $440.70M | (m) | (m) | $739.00K |
|---|
| 2018-12-31 | Reported | (m) | $31.09M | (m) | $345.28M | (m) | $9.95M | $68.43M | $293.38M | (m) | (m) | -$2.10M |
|---|